共 50 条
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal
被引:620
作者:
Fife, Brian T.
[1
,2
]
Pauken, Kristen E.
[2
]
Eagar, Todd N.
[1
,3
]
Obu, Takashi
[2
]
Wu, Jenny
[1
]
Tang, Qizhi
[1
,4
]
Azuma, Miyuki
[5
]
Krummel, Matthew F.
[6
]
Bluestone, Jeffrey A.
[1
]
机构:
[1] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA
[2] Univ Minnesota, Dept Med, Ctr Immunol, Minneapolis, MN 55455 USA
[3] Univ Texas SW, Dept Neurol, Dallas, TX USA
[4] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[5] Tokyo Med & Dent Univ, Dept Mol Immunol, Tokyo, Japan
[6] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA
基金:
美国国家卫生研究院;
关键词:
T-CELL-ACTIVATION;
NONOBESE DIABETIC MICE;
LYMPH-NODES;
IN-VIVO;
DENDRITIC CELLS;
NEGATIVE REGULATOR;
PROGRAMMED DEATH-1;
IMMUNE-SYSTEM;
CTLA-4;
EXPRESSION;
D O I:
10.1038/ni.1790
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Programmed death 1 (PD-1) is an inhibitory molecule expressed on activated T cells; however, the biological context in which PD-1 controls T cell tolerance remains unclear. Using two-photon laser-scanning microscopy, we show here that unlike naive or activated islet antigen-specific T cells, tolerized islet antigen-specific T cells moved freely and did not swarm around antigen-bearing dendritic cells (DCs) in pancreatic lymph nodes. Inhibition of T cell antigen receptor (TCR)-driven stop signals depended on continued interactions between PD-1 and its ligand, PD-L1, as antibody blockade of PD-1 or PD-L1 resulted in lower T cell motility, enhanced T cell-DC contacts and caused autoimmune diabetes. Blockade of the immunomodulatory receptor CTLA-4 did not alter T cell motility or abrogate tolerance. Thus, PD-1-PD-L1 interactions maintain peripheral tolerance by mechanisms fundamentally distinct from those of CTLA-4.
引用
收藏
页码:1185 / U70
页数:9
相关论文